NCT00267384View on ClinicalTrials.gov

N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

September 30, 2008

Conditions
Drug Induced Nephrotoxicity
Interventions
DRUG

Oral N-Acetylcysteine

Trial Locations (1)

POB 151

Soroka University Medical Center, Beersheba

All Listed Sponsors
lead

Soroka University Medical Center

OTHER

NCT00267384 - N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity | Biotech Hunter | Biotech Hunter